Gingival Patents (Class 514/902)
  • Patent number: 8975275
    Abstract: The invention relates to the use of chemotherapeutic agents for the production of a medicament for the topical and/or local treatment of diseases caused by bacteria and/or for prophylaxis in humans or animals.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: March 10, 2015
    Assignee: Bayer Innovation GmbH
    Inventors: Hans-Herrmann Schulz, Günther Schlimbach
  • Patent number: 8945596
    Abstract: The present invention relates to an antimicrobial composition. It particularly relates to an antimicrobial composition for cleansing or personal care. It is an object of the present invention to provide antimicrobial compositions that have relatively fast antimicrobial action. Present inventors have surprisingly found that compositions comprising selected ingredients, namely thymol and terpineol, in selective proportions provide relatively quick antimicrobial action.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: February 3, 2015
    Assignee: Conopco, Inc.
    Inventors: Amit Chakrabortty, Srilaxmi Venkata Medepalli
  • Patent number: 8795638
    Abstract: This invention pertains to dental care compositions with antimicrobial benefits. In particular, the invention provides for compositions of oral tissue-adherent salts that release biocidal ions on a controlled release basis and thereby provide and maintain an essentially uniform concentration of biocidal ions above the MBC or MIC of the target bacteria at the site of application in the mouth for an extended period of time. The compositions are useful for treating or preventing oral diseases resulting from bacteria, fungal or yeast infections, such as caries, gingivitis, periodontal disease and candidiasis.
    Type: Grant
    Filed: October 6, 2011
    Date of Patent: August 5, 2014
    Assignee: Nevada Naturals Inc.
    Inventors: Anthony Errol Winston, Richard F. Stockel, Anthony Joseph Sawyer
  • Patent number: 8652444
    Abstract: Antiplaque oral compositions are provided that contain an orally acceptable carrier and an antibacterial effective amount of the compound of formula (I). In various embodiments, the compositions contain from about 0.001% to about 10% by weight of the compound of formula (I).
    Type: Grant
    Filed: November 9, 2011
    Date of Patent: February 18, 2014
    Assignee: Colgate-Palmolive Company
    Inventors: Ravi Subramanyam, Prem Sreenivasan
  • Patent number: 8383170
    Abstract: Provided, among other things, is a method of treating or ameliorating an indication of mucosal or adjacent tissue comprising periodically applying to mucosa at or adjacent to disease affected tissue a rinse comprising: an effective amount of appropriate composition of herbal bioactive comprising active(s) of one or more of Sambucus nigra, Centella asiatica or Echinacea purpurea; an antimicrobially effective amount of a quaternary ammonium surfactant; and optionally a polymer or mixture of polymers effective to coat said tissue and entrap said extract(s).
    Type: Grant
    Filed: November 8, 2011
    Date of Patent: February 26, 2013
    Assignee: Izun Pharmaceuticals Corporation
    Inventors: Zvi G. Loewy, William Zev Levine, Aron J. Saffer
  • Patent number: 8377424
    Abstract: This invention relates to a method of therapeutic or prophylactic treatment of periodontal disease comprising administering to a subject in need thereof a polymeric compound of formula An. Also disclosed and claimed is an article of manufacture comprising the above compounds packaged within a container with instructions for use, and methods of making thereof.
    Type: Grant
    Filed: December 3, 2004
    Date of Patent: February 19, 2013
    Assignee: Mars, Incorporated
    Inventors: Leo J. Romanczyk, Jr., Harold H. Schmitz
  • Patent number: 8343483
    Abstract: New strains of Lactobacillus that have been selected for their capability of improved reduction the number of Streptococcus mutans in the mouth of mammals through inhibiting activity in combination with better binding to the oral mucins and dental plaque, thereby preventing, reducing or treating dental caries, and products derived from said strains, including agents for treatment or prophylaxis of caries for administration to humans.
    Type: Grant
    Filed: October 15, 2008
    Date of Patent: January 1, 2013
    Assignee: Biogaia AB
    Inventors: Bo Mollstam, Eamonn Connolly
  • Patent number: 7972137
    Abstract: Compositions and methods are directed to antimicrobial compositions and articles that release ?NO from the composition and/or article in an amount effective to prevent gingival and other oral mucosal diseases.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: July 5, 2011
    Inventor: Gerald M. Rosen
  • Patent number: 7955591
    Abstract: Disclosed is a method of promoting oral hygiene and teeth re-calcification involving increasing crevicular fluid flow in a subject in the presence of hydroxide containing material such that OH? ions are formed and caused to contact the teeth. The method further involves causing calcium Ca++ ion containing material to simultaneously, or subsequently, contact the teeth.
    Type: Grant
    Filed: July 26, 2005
    Date of Patent: June 7, 2011
    Inventor: Janet M. Wehrli
  • Patent number: 7850996
    Abstract: The use of selenite- or selenate-containing preparations supplemented with pharmaceutically acceptable or food-compatible acids for the preparation of an agent intended for topical or buccal application or mucosal administration is described.
    Type: Grant
    Filed: December 4, 2002
    Date of Patent: December 14, 2010
    Assignee: Vis-Vitalis Lizenz-Und Handels AG
    Inventors: Peter Kössler, Norbert Fuchs, Bodo Kuklinski
  • Patent number: 7846422
    Abstract: The present invention relates to a method for prevention or treatment of periodontal diseases, containing administering lignans represented by the following formula (1) (wherein R1 represents a hydrogen atom or a hydroxyl group; R2, R3, R4 and R5 are the same or different and each represents a hydrogen atom, a hydroxyl group, a C1-10 alkyl group, a hydroxy C1-10 alkyl group or a C1-10 alkoxy group) or plant extracts containing the lignans.
    Type: Grant
    Filed: August 3, 2004
    Date of Patent: December 7, 2010
    Assignee: Kao Corporation
    Inventors: Kazushi Oshino, Ikuhisa Ichimura, Hisataka Kobayashi, Minoru Takizawa, Hidetake Fujinaka
  • Patent number: 7829067
    Abstract: A composition and method for treating periodontal infections and gingivitis includes an extract of Centipeda cunninghami, coenzyme Q10, aloe vera and folic acid. The composition also contains additional plant extracts and nutrients that are effective in cell reproduction, wound healing and provide antibacterial and anti-inflammatory effects. The composition is applied to the teeth and gums to inhibit bacterial growth and reduce inflammation of the gums.
    Type: Grant
    Filed: March 3, 2004
    Date of Patent: November 9, 2010
    Assignee: Bio-Botanica, Inc.
    Inventors: Frank S. D'Amelio, Sr., Youssef W. Mirhom
  • Patent number: 7776914
    Abstract: The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions of the present invention have the advantage of increased stability, a reduction of arachidonic acid in cells, a reduction in eicosanoid production and enhanced cell regulation and communication. Also disclosed are methods for using the compositions for treatment and prevention.
    Type: Grant
    Filed: June 16, 2009
    Date of Patent: August 17, 2010
    Assignee: Imagenetix, Inc.
    Inventors: William P. Spencer, Patrick S. Millsap
  • Patent number: 7652000
    Abstract: Methods of treating and/or preventing surface infections, such as acne, in an animal, such as a human being, using antibiotics incorporating borinic acid complexes, especially picolinic acid derivatives, are disclosed, along with compositions of these antibiotics.
    Type: Grant
    Filed: June 14, 2005
    Date of Patent: January 26, 2010
    Assignee: Anacor Pharmaceuticals, Inc.
    Inventors: David Perry, Kirk R. Maples, Carolyn Bellinger-Kawahara
  • Patent number: 7612111
    Abstract: The invention is directed to compositions comprising lecithin, olive oil, esterified fatty acids and mixed tocophenols for use in the treatment and prevention of various types of arthritis and other inflammatory joint conditions, periodontal diseases and psoriasis, which avoid many of the side effects associated with known treatments. The compositions of the present invention have the advantage of increased stability, a reduction of arachidonic acid in cells, a reduction in eicosanoid production and enhanced cell regulation and communication. Also disclosed are methods for using the compositions for treatment and prevention.
    Type: Grant
    Filed: March 22, 2004
    Date of Patent: November 3, 2009
    Assignee: Imagenetix, Inc.
    Inventors: William P. Spencer, Patrick S. Millsap
  • Patent number: 7279151
    Abstract: This invention relates to novel dental compositions and methods for preventing dental plaque and caries formation and generally for inhibiting tooth decay and brightening/whitening teeth. The compositions of this invention comprise herbs such as Citrus karna raf., Zanthoxylum armatum D.C. and Azadirachta indica A. Juss. thereof which can be combined with pharmaceutically acceptable carriers or diluents to be administered in the form of conventional dental compositions. The compositions of the present invention, also preferably, contain Mint.
    Type: Grant
    Filed: March 25, 2004
    Date of Patent: October 9, 2007
    Assignee: Council of Scientific and Industrial Research
    Inventors: Palpu Pushpangadan, Chandana Venkateswara Rao, Sanjeev Kumar Ojha, Kuttan Pillai Narayanan Nair, Madan Mohan Pandey, Ajay Kumar Singh Rawat, Shanta Mehrotra
  • Patent number: 7129218
    Abstract: Various methods are provided, including re-epithelization and wound healing with reduced fibrosis, particularly for the re-epithelization of mucous membrane tissues, most particularly for the treatment and prevention of gum disease and for periodontal regeneration, each of which uses administration of a composition containing one or more rhamnolipids as an active ingredient. The figure provides a graphical representation of the effects of topical BAC-3 on the rate of burn wound closure.
    Type: Grant
    Filed: August 7, 2000
    Date of Patent: October 31, 2006
    Assignee: Paradigm Biomedical, Inc.
    Inventors: Tamara Stipcevic, Tihana Piljac, Jasenka Piljac, Tatjana Dujmic, Goran Piljac
  • Patent number: 7087249
    Abstract: The invention relates to the use of one or more antimicrobial metals preferably selected from silver, gold, platinum, and palladium but most preferably silver, formed with atomic disorder, and preferably in a nanocrystalline form, for reducing inflammation or infection of the mucosal membrane. The antimicrobial metal may be formulated as, or used in the form of, a nanocrystalline coating of one or more antimicrobial or noble metals, a nanocrystalline powder of one or more antimicrobial or noble metals, or a liquid or solution containing dissolved species from a nanocrystalline powder or coating of one or more antimicrobial or noble metals.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: August 8, 2006
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Robert Edward Burrell, Antony George Naylor, Peter Howard Moxham
  • Patent number: 7048910
    Abstract: The invention relates to the use of one or more compounds selected from compounds of formulae Ia and Ib, the physiologically compatible salts of compounds of formula Ia and Ib and the stereoisomer forms of compounds of formula La and Ib, wherein R1, R2, R3, R4 and n have the meaning cited in claim 1.
    Type: Grant
    Filed: August 8, 2001
    Date of Patent: May 23, 2006
    Assignee: Merck Patent GmbH
    Inventors: Joachim Buenger, Hansjuergen Driller, Olaf den Hollander
  • Patent number: 7029690
    Abstract: Disclosed are articles and oral compositions which enable positioning material(s) which absorb oral fluids into controlled, direct contact with at least one dental arch, or portion thereof, of a subject at the location where teeth emerge from dental arch gum tissue, in a manner conducive to increasing crevicular fluid flow while maintaining a relatively dry application field for a therapeutic and/or cosmetic result effecting period of time. The method is applicable to introduction of gingivally absorbed substances and to treatment of, for instance, periodontal gum disease wherein bacteria is swept along in the crevicular fluid and lysed.
    Type: Grant
    Filed: November 4, 2002
    Date of Patent: April 18, 2006
    Assignee: Clinically Clean Inc.
    Inventor: Janet M. Wehrli
  • Patent number: 6919070
    Abstract: A stomatic composition has particles of hydroxyapatite with an average particle size in length (l), width (d) and thickness (h) of: l from 0.2 ?m to about 0.01 ?m, d from about 0.1 ?m to about 0.001 ?m and h from about 0.1 ?m to about 0.001 ?m.
    Type: Grant
    Filed: October 17, 1997
    Date of Patent: July 19, 2005
    Assignee: Zakrytoe Aktsionernoe Obschestvo “OSTIM”
    Inventors: Vsevolod Nikolaevich Rudin, Vladislav Petrovich Zuev, Vladimir Fedorovich Komarov, Igor Vitallevich Melikhov, Vladimir Vasillevich Minaev, Andrei Yurlevich Orlov, Anatoly Aleksandrovich Mishin, Viktor Evgenievich Bozhevolnov
  • Patent number: 6902738
    Abstract: Topical oral dosage forms containing bismuth compounds are described, which are useful for treating H. pylori and other bacterial infections that cause gastrointestinal disorders and halitosis, as well as for treating ocular and dermal wounds. Methods of employing topical oral dosage forms for treating bacterial infections that cause gastrointestinal disorders and halitosis, and for treating ocular and dermal wounds, are also described.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: June 7, 2005
    Assignee: Josman Laboratories, Inc.
    Inventors: Scott A. Gubler, Narayan K. Athanikar
  • Patent number: 6863904
    Abstract: The present invention relates to compositions without added iron and methods for prophylactic nutritional supplementation and therapeutic nutritional supplementation. Specifically, the method involves administering to an individual a composition comprising carotenoids, vitamin E, vitamin D, vitamin C, thiamine, riboflavin, niacin, folic acid, pyridoxine, biotin, pantothenic acid, cobalamin, magnesium, manganese, zinc, selenium, chromium, copper, alpha lipoic acid, and lutein, wherein the composition is free of added iron.
    Type: Grant
    Filed: October 14, 2003
    Date of Patent: March 8, 2005
    Assignee: Everett Laboratories, Inc.
    Inventors: John A. Giordano, Charles Balzer
  • Patent number: 6770268
    Abstract: A non-foaming periodontic composition in a gel form or mouth wash for treating gum diseases or used in bleaching teeth which are alcohol free. The composition is a mixture of an isoalkyl amine oxide and an antimicrobial betaine compound. The composition is useful for treating gum disease and whitening teeth.
    Type: Grant
    Filed: May 21, 2003
    Date of Patent: August 3, 2004
    Assignee: Oratec Corp.
    Inventors: Dave Hall, James R. Hunt
  • Patent number: 6669931
    Abstract: A method of treating dental carries and remineralizing lesions includes the steps of directing a stream of oxidizing gas onto a carious lesions for a period of time sufficient to kill microorganisms within the carious lesion; and thereafter applying to the lesion a remineralization formulation.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: December 30, 2003
    Assignee: Curozone Ireland Limited
    Inventors: Edward Lynch, Jurgen Schemmer
  • Patent number: 6670343
    Abstract: An agent for periodontal disease includes, as an active component, a methanebisphosphonic acid derivative or a hydrate thereof represented by the general formula (I): [wherein X, Y, m, n, The methanebisphosphonic acid derivative represented by the general formula (I) or a hydrate thereof according to the present invention has activities such as inhibitory effect on cell infiltration to the affected part associated with periodontal disease, and is useful for the prophylaxis or treatment of periodontal disease.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: December 30, 2003
    Assignee: Toray Industries, Inc.
    Inventors: Masatoshi Ito, Seiji Okazaki, Yuriko Kawai, Norio Kawabe
  • Patent number: 6649148
    Abstract: A reductant rinse including xylitol prevents buildup in ozone carrying lines in apparatus for the treatment of dental caries.
    Type: Grant
    Filed: March 12, 2002
    Date of Patent: November 18, 2003
    Assignee: Curozone Ireland Limited
    Inventors: Edward Lynch, Jurgen Schemmer
  • Patent number: 6605268
    Abstract: Provided with a tooth paste composition which contains an abrasive cleaning agent, a humectant, a binder or thickener and a flavouring agent, the tooth paste, and includes a rose-seed oil, wherein the rose-seed oil is contained in an amount of 1-6% by weight based on the total weight of the tooth paste composition.
    Type: Grant
    Filed: September 12, 2001
    Date of Patent: August 12, 2003
    Inventor: Myung Woo Jung
  • Patent number: 6589511
    Abstract: The composition for forming solid particles of the present invention comprises a biodegradable polymer, a solvent, a polyhydric alcohol, a viscosity-increasing agent, and an active drug, wherein the composition is in the form of an emulsion comprising a continuous phase rich in the polyhydric alcohol and the viscosity-increasing agent and a dispersed phase of liquid particles rich in the biodegradable polymer and the solvent, the dispersed phase being present in said continuous phase. The above composition can allow the carrier comprising an active drug to reach all corners of narrow periodontal pockets, and the carrier comprising the active drug has high retention in the periodontal pockets, whereby making it possible to maintain the active drug for a long period of time at a high concentration.
    Type: Grant
    Filed: September 17, 1999
    Date of Patent: July 8, 2003
    Assignee: Sunstar, Inc.
    Inventor: Yasumitsu Shimizu
  • Patent number: 6576226
    Abstract: The present invention relates to compositions and methods of treating periodontal disease and related disorders utilizing a sustained, controlled release targeted delivery method to effectively disrupt and inhibit bacterial biofilms at periodontal treatment sites.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: June 10, 2003
    Inventor: Gary R. Jernberg
  • Patent number: 6565895
    Abstract: The invention relates to the unexpected discovery that bismuth-containing compounds are effective in the treatment of oral mucositis in a mammal. Thus, the invention relates, in one aspect to a method of treating oral mucositis comprising administering an effective amount of a pharmaceutically acceptable bismuth-containing compound, such as a bismuth salt or bismuth complex. In a preferred embodiment, the bismuth compound is an organic or inorganic salt such as, bismuth subsalicylate, bismuth subgallate, bismuth aluminate, bismuth citrate, bismuth subcitrate, bismuth carbonate, bismuth subcarbonate, tripotassium dicitrato bismuthate, bismuth nitrate, bismuth subnitrate, bismuth tartrate and mixtures thereof, preferably, bismuth subsalicylate and bismuth subgallate.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: May 20, 2003
    Assignee: GelTex Pharmaceuticals, Inc.
    Inventors: Philip J. Goddard, Jeffrey D. Klinger, Pradeep K. Dhal, W. Harry Mandeville, III, Richard J. Fitzpatrick, Thomas X. Neenan
  • Patent number: 6528038
    Abstract: The present invention provides a composition for use in raising an immune response directed against Porphyromonas gingivalis. The composition includes a suitable adjuvant and/or acceptable carrier and one substantially purified P. gingivalis immunogen. The immunogen is selected from the group consisting of Antigen 1, Antigen 2, Antigen 3, Antigen 4 and epitope containing fragments thereof, in which: Antigen 1 is an antigen of P. gingivalis and has an internal amino acid sequence:DLENKGEATLLVTFGSSYKAPRETYAKIEKTFAAAYPDQR; Antigen 2 is an antigen of P. gingivalis and has an internal amino acid sequence: DNPDENPLEGDITQTHTEKYVLAED; Antigen 3 is an antigen of P. gingivalis and has an internal amino acid sequence: DVLLLDVTPLSLGIETMGGVMTYLIDANTTIPKLK; Antigen 4 is an antigen of P. gingivalis and has an internal amino acid sequence: VYNASISAVGNTSAIDPVVQIIHHN.
    Type: Grant
    Filed: July 7, 1998
    Date of Patent: March 4, 2003
    Assignee: The University of Melbourne
    Inventors: Eric Charles Reynolds, Nada Slakeski, Anne Hendtlass
  • Patent number: 6444709
    Abstract: The invention relates to novel heteroethynylenic compounds having the general formula (I): as well as to the use of these compounds in pharmaceutical compositions intended for use in human or veterinary medicine (dermatological, rheumatic, respiratory, cardiovascular and ophthalmological complaints in particular), or alternatively in cosmetic compositions.
    Type: Grant
    Filed: February 7, 2000
    Date of Patent: September 3, 2002
    Assignee: Galderma Research & Development S.N.C.
    Inventors: Philippe Diaz, Jean-Michel Bernardon
  • Patent number: 6426085
    Abstract: This invention provides for a method for treatment of corneal and dermal wounds by administering bismuth compounds in topical dosage forms. Bismuth compounds cause stimulation of release of growth factors in damaged tissue to promote regeneration of epithelial cells and hence accelerate wound healing. These bismuth compounds also have good antimicrobial activity against several anaerobic bacteria involved in diaper rash exacerbation.
    Type: Grant
    Filed: May 24, 2000
    Date of Patent: July 30, 2002
    Assignee: Josman Laboratories Inc.
    Inventor: Narayan K. Athanikar
  • Patent number: 6423300
    Abstract: The present invention relates to an oral composition containing a zinc compound containing free available zinc ion and at least one stabilized or stable Eh raising compound distributed in an oral vehicle. The present invention further relates to a method of inhibiting the formation of sulfur containing anions and preventing a reduction in the Eh of the oral cavity. A method of reducing oral malodor and gingivitis and periodontitis is also provided by this invention.
    Type: Grant
    Filed: February 17, 2000
    Date of Patent: July 23, 2002
    Assignee: The Research Foundation of State University of New York
    Inventors: Israel Kleinberg, Milroy Codipilly
  • Patent number: 6340455
    Abstract: Skin prick test for the determination of the predisposition of an individual to develop marginal periodontitis, said kit comprising: (a) a first reagent containing a known quantity of a surface structure common to anaerobic Gram negative pathogens which is capable of triggering the inflammatory response associated with periodontitis and gingivitis; (b) second reagent containing an agonist to said individual; (c) a negative control; and (d) instructions for the use of said kit; and a method for such determination of predisposition.
    Type: Grant
    Filed: June 23, 1999
    Date of Patent: January 22, 2002
    Assignee: Peridoc AB
    Inventors: Leif Blomlöf, Sven Lindskog, Olle Zetterström
  • Patent number: 6325991
    Abstract: The present invention relates to methods of treating periodontal disease in a mammal. The methods include administering to an animal an s effective amount of an inhibitor of sPLA2. The inhibitors may be advantageously delivered as a composition that includes various carriers. In certain aspects of the invention, inhibitors used in the method include substituted indole or substituted pyrrole sPLA2 inhibitors. Also provided are compositions that include the sPLA2 carriers for oral delivery of the inhibitors.
    Type: Grant
    Filed: August 24, 1999
    Date of Patent: December 4, 2001
    Inventor: Susan E. Draheim
  • Patent number: 6280775
    Abstract: This invention provides a liquid antimicrobial composition that is particularly useful as a mouthwash for treating or reducing the risk of dental disease. The composition is prepared by mixing a first solution comprising a water soluble metal chlorite compound with a second solution comprising sodium persulfate and hydrogen peroxide. The resulting composition, containing chlorine dioxide, is preferably used at the time of preparation by applying the composition to the locus where treatment is desired.
    Type: Grant
    Filed: May 19, 2000
    Date of Patent: August 28, 2001
    Inventors: Joseph Alan Sasson, Riccardo Panicucci
  • Patent number: 6264966
    Abstract: This invention involves the use of a class of compounds with chelation affinity and selectivity for first transition series elements. Application or administration of the free or conjugated compound, or physiological salts of the free or conjugated compound, results in decrease of the bioavailability and/or chemical action of first transition series elements. These characteristics make such compounds useful in cosmetics and personal care products to decrease odor arising from microbial growth on body surfaces and in body cavities, decrease microbial growth on teeth, plaque, and gums that cause tooth decay and gum disease, inhibition of oxidative damage to the skin, inhibition of enzymatic action of metalloenzymes dependent on first transition series elements, and inhibition of reperfusion injury.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: July 24, 2001
    Assignee: Concat, Ltd.
    Inventors: Harry S. Winchell, Joseph Y. Klein, Elliot D. Simhon, Rosa L. Cyjon, Ofer Klein, Haim Zaklad
  • Patent number: 6248309
    Abstract: Gum compositions containing effective amounts of antimicrobial agents that are released to the oral cavity during chewing. In specific embodiments, the antimicrobial agents are released from the gum at different rates and times.
    Type: Grant
    Filed: August 19, 1999
    Date of Patent: June 19, 2001
    Assignee: Optiva Corporation
    Inventors: Lokanathan M. Iyer, Dawn E. Barkans, Brian D. Hench
  • Patent number: 6228347
    Abstract: A gel, paste, gum or lozenge composition for oral application to human gums to prevent and reduce symptoms of gum disease. The composition includes reduced glutathione and a source of selenium.
    Type: Grant
    Filed: September 29, 1998
    Date of Patent: May 8, 2001
    Assignee: Thione International, Inc.
    Inventor: Theodore Hersh
  • Patent number: 6218389
    Abstract: The invention provides compounds of formula as described in the claims, or an optical isomer, diastereomer or enantiomer thereof, or a pharmaceutically-acceptable salt, or biohydrolyzable amide, ester, or imide thereof are useful as inhibitors of metalloproteases. Also disclosed are pharmaceutical compositions and methods of treating diseases, disorders and conditions characterized by metalloprotease activity using these compounds or the pharmaceutical compositions containing them.
    Type: Grant
    Filed: July 31, 1998
    Date of Patent: April 17, 2001
    Assignee: The Procter & Gamble Co.
    Inventors: Neil Gregory Almstead, Roger Gunnard Bookland, Yetunde Olabisi Taiwo, Rimma Sandler Bradley, Rodney Dean Bush, Biswanath De, Michael George Natchus, Stanislaw Pikul
  • Patent number: 6172032
    Abstract: A composition comprising: an organic chemical having a chemical group having a dipole moment of at least about 1.5 Debyes and a chemical linker selected from the group consisting of carboxylic acids having 4 to 6 carbon atoms, an ethoxylated polyhydric alcohol, a polyvinyl pyrrolidone and a polyethylene glycol having a molecular weight of about 600 to about 10,000, wherein the molar ratio of organic chemical to chemical linker is about 4:1 to 1:4.
    Type: Grant
    Filed: November 17, 1999
    Date of Patent: January 9, 2001
    Assignee: Colgate-Palmolive Co
    Inventors: Michele Davister, Guy Broze, Patrick Durbut, Hoai-Chau Cao, Anne-Marie Misselyn, Thomas Connors, John Labows
  • Patent number: 6074674
    Abstract: The present invention provides, inter alia, formulations useful to ameliorate symptoms associated with mucosal abrasions, specifically those due to dental orthodontic brackets; oral surgery; periodontal surgery or other procedures. For instance, there is a formulation comprising: 65 to 75% microcrystalline wax; 5 to 15% non-ionic polymer; 15 to 25% topical anesthetic; and 1 to 5% surfactant, wherein the ratio of non-ionic polymer to microcrystalline wax is no greater than 0.2. Preferably, for solid topical anesthetics, the particle size is less than the apertures of a 100-mesh screen. However, the topical anesthetic may also be a liquid. Formulations wherein the mixture is a homogeneous matrix is preferred.
    Type: Grant
    Filed: July 20, 1998
    Date of Patent: June 13, 2000
    Assignee: University of Kentucky Research Foundation
    Inventors: Michael Joseph Jay, G. Thomas Kluemper, Sang Hun Kim
  • Patent number: 6045800
    Abstract: The present invention provides a composition for preventing or treating periodontal diseases comprising an extract of Achyranthis radix, Ulmus cortex or a mixture thereof which inhibits the productions of superoxide, prostaglandin, and interleukin (IL-1.beta.) which are inducers for periodontal diseases and inhibits the enzyme activity of collagenase which decomposes collagen protein which is a substrate for the periodontal tissues, and at the same time promotes collagen protein synthesis, thereby treating periodontal diseases efficiently.
    Type: Grant
    Filed: February 26, 1998
    Date of Patent: April 4, 2000
    Assignee: LG Chemical Ltd.
    Inventors: Moon Moo Kim, Sang Nyun Kim, Jae Kyun Seok, Kyung Chul Choi
  • Patent number: 6028110
    Abstract: A pharmaceutical or veterinary composition comprising a compound of formula I ##STR1## wherein X is a --CO.sub.2 H group and R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5 are as defined in the specification, or a salt, hydrate or solvate thereof, and a pharmaceutically or veterinarily acceptable excipient or carrier. A method of treatment of diseases or conditions mediated by MMPs in mammals, such as rheumatoid arthritis, osteoarthritis, periodontitis, gingivitis, corneal ulceration or tumour invasion by secondary means, by administering to the mammal an effective amount of the composition.
    Type: Grant
    Filed: November 22, 1996
    Date of Patent: February 22, 2000
    Assignee: British Biotech Pharmaceuticals Ltd.
    Inventors: Andrew Miller, Raymond Paul Beckett, Fionna Mitchell Martin, Mark Whittaker
  • Patent number: 5998390
    Abstract: Tissue-destructive conditions related to excess proteinase activity in a biological system are treated or prevented by administering to the system a composition which combines a tetracycline and a bisphosphonate in synergistic proteinase inhibiting amounts.
    Type: Grant
    Filed: September 28, 1998
    Date of Patent: December 7, 1999
    Assignee: The Research Foundation of State University of New York
    Inventors: Nungavarm S. Ramamurthy, Lorne M. Golub, Timo A. Sorsa, Olli P. Teronen, Tuula A. Salo
  • Patent number: 5989522
    Abstract: The invention relates to an oral composition for prevention of mycotic infections of the oral cavity comprising an antifungal compound embedded in a sustained release carrier such as a cellulosic polymer, and a method for the use of said composition in preventing microfungal infections in the oral cavity. The invention also provides for the supplementation of said oral composition with an adhesive and a plasticizer to increase antifungal effectiveness.
    Type: Grant
    Filed: April 6, 1995
    Date of Patent: November 23, 1999
    Assignee: Yissum Research & Development Company of the Hebrew University of Jerusalem
    Inventor: Michael Friedman
  • Patent number: 5955407
    Abstract: A composition comprising: an organic chemical having a chemical group having a dipole moment of at least about 1.5 Debyes and a chemical linker selected from the group consisting of carbovlic acids having 4 to 6 carbon atoms, an ethoxylated polyhydric alcohol, a polyvinyl pyrrolidone and a polyethylene glycol having a molecular weight of about 600 to about 10,000, wherein the molar ratio of organic chemical to chemical linker is about 4:1 to 1:4.
    Type: Grant
    Filed: October 1, 1998
    Date of Patent: September 21, 1999
    Assignee: Colgate-Palmolive Co.
    Inventors: Michele Davister, Guy Broze, Patrick Durbut, Hoai-Chau Cao, Thomas Connors, John Labows, Anne-Marie Misselyn
  • Patent number: RE36419
    Abstract: The present invention provides novel methods for prevention or treatment of primary and recurring squamous cell carcinoma of the oral cavity or oropharynx comprising topical administration, to the oral cavity or oropharynx, of an effective amount of an NSAID, especially a composition administering from about 0.001% to about 0.2% ketorolac to the oral cavity, alone or as an adjunct to surgery and/or radiation therapy.
    Type: Grant
    Filed: March 27, 1998
    Date of Patent: November 30, 1999
    Assignee: The Procter & Gamble Company
    Inventor: Paul Francis Cavanaugh, Jr.